Samba Biologics INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSouth Hero, VT
SAM.gov UEIFHEJW958JKD8
Samba BioLogics is a preclinical stage biotechnology company that develops biologic drugs for regenerative medicine, specifically targeting heart disease and tissue preservation after injury. The company produces agonist biologics, including two named products: Cell-Kro, which promotes engraftment of transplanted progenitor cells, and VasaPlex, which rescues cardiac tissue after myocardial infarction. The company serves the regenerative medicine and cardiac treatment industries.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Samba Biologics INC. | South Hero | VT | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.